Targeted & controlled bone healing
  • slidebg1
  • slidebg1
  • slidebg1
Kuros has spent more than a decade refining technologies that instruct the body to form bone using targeted and controlled mechanisms of action.

Kuros Biosciences are experts in the science of orthobiologics.

Our technology platforms aim to deliver improved patient outcomes through targeted and controlled bone healing.

We are poised to realise this aim through the launch of MagnetOs, based on our flagship surface science technology, and through the expansion of our portfolio by the continued clinical development of products based on our novel TG Hook technology.

Latest News
02 Jul 18
Kuros Biosciences reports first U.S. & UK sales of MagnetOs Commercial roll-out in the U.S. and Europe on track


19 Jun 18
Kuros Biosciences to present promising clinical case studies with MagnetOs at leading spine surgery conference
Kuros Biosciences will this week present results from several investigator-led clinical case studies of MagnetOs Granules at the 15 th annual State of Spine Surgery Think Tank, a leading conference uniquely... READ MORE


Kuros Biosciences AG
Wagistrasse 25, 8952 Schlieren, Switzerland
Tel: +41 44 733 47 47   Fax: +41 44 733 47 40   Email: info@kurosbio.com

About Kuros

  1. Overview
  2. Executive Committee
  3. Board
  4. Careers

Products

  1. MagnetOs

Pipeline

  1. Pipeline
  2. Spinal fusion
    KUR-113
  3. Fracture repair
    KUR-111
    KUR-113
  4. Surgical Sealants
    Neuroseal (KUR-023)

Technologies

  1. Surface Science Technology
  2. Fibrin-Based
  3. Synthetic Cross-Linking Technology
  4. Immune Modulation

Partnerships

  1. Collaborations
  2. Business Development

Investors

  1. Share price
  2. Regulatory filings
  3. Reports & Presentations
  4. Calendar
  5. Corporate governance
  6. Stay informed

News

  1. Press releases
  2. Conferences & Events

Contact

  1. Location
Kuros has spent more than a decade refining technologies that instruct the body to form bone using targeted and controlled mechanisms of action.

Kuros Biosciences are experts in the science of orthobiologics.

Our technology platforms aim to deliver improved patient outcomes through targeted and controlled bone healing.

We are poised to realise this aim through the launch of MagnetOs, based on our flagship surface science technology, and through the expansion of our portfolio by the continued clinical development of products based on our novel TG Hook technology.

Latest News
02 Jul 18
Kuros Biosciences reports first U.S. & UK sales of MagnetOs Commercial roll-out in the U.S. and Europe on track


19 Jun 18
Kuros Biosciences to present promising clinical case studies with MagnetOs at leading spine surgery conference
Kuros Biosciences will this week present results from several investigator-led clinical case studies of MagnetOs Granules at the 15 th annual State of Spine Surgery Think Tank, a leading conference uniquely... READ MORE